- Patent Title: Predicting response to immunotherapy using computer extracted features of cancer nuclei from hematoxylin and eosin (HandE) stained images of non-small cell lung cancer (NSCLC)
-
Application No.: US16281324Application Date: 2019-02-21
-
Publication No.: US11055844B2Publication Date: 2021-07-06
- Inventor: Anant Madabhushi , Xiangxue Wang , Cristian Barrera , Vamsidhar Velcheti
- Applicant: Case Western Reserve University
- Applicant Address: US OH Cleveland
- Assignee: Case Western Reserve University
- Current Assignee: Case Western Reserve University
- Current Assignee Address: US OH Cleveland
- Agency: Eschweiler & Potashnik, LLC
- Main IPC: G06K9/00
- IPC: G06K9/00 ; G06T7/00 ; G06K9/46 ; G06T7/40 ; G06T7/62 ; G06K9/62 ; G06T7/11 ; G16H30/40 ; G16H50/20

Abstract:
Embodiments access a digitized image of tissue demonstrating non-small cell lung cancer (NSCLC), the tissue including a plurality of cellular nuclei; segment the plurality of cellular nuclei represented in the digitized image; extract a set of nuclear radiomic features from the plurality of segmented cellular nuclei; generate at least one nuclear cell graph (CG) based on the plurality of segmented nuclei; compute a set of CG features based on the nuclear CG; provide the set of nuclear radiomic features and the set of CG features to a machine learning classifier; receive, from the machine learning classifier, a probability that the tissue will respond to immunotherapy, based, at least in part, on the set of nuclear radiomic features and the set of CG features; generate a classification of the tissue as a responder or non-responder based on the probability; and display the classification.
Public/Granted literature
Information query